We are live on ! Find out more

1,014 hedge funds and large institutions have $59B invested in Biogen in 2017 Q3 according to their latest regulatory filings, with 99 funds opening new positions, 380 increasing their positions, 356 reducing their positions, and 68 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more funds holding in top 10

Funds holding in top 10: 2338 (+15)

46% more first-time investments, than exits

New positions opened: 99 | Existing positions closed: 68

16% more capital invested

Capital invested by funds: $50.9B → $59B (+$8.14B)

2% more funds holding

Funds holding: 9921,014 (+22)

1.38% more ownership

Funds ownership: 87.77%89.15% (+1.4%)

7% more repeat investments, than reductions

Existing positions increased: 380 | Existing positions reduced: 356

22% less call options, than puts

Call options by funds: $974M | Put options by funds: $1.24B

Holders
1,014
Holders Change
+22
Holders Change %
+2.22%
% of All Funds
25.28%
Holding in Top 10
38
Holding in Top 10 Change
+15
Holding in Top 10 Change %
+65.22%
% of All Funds
0.95%
New
99
Increased
380
Reduced
356
Closed
68
Calls
$974M
Puts
$1.24B
Net Calls
-$269M
Net Calls Change
-$87M
Name Holding Trade Value Shares
Change
Change in
Stake
HAI
476
Hennessy Advisors Inc
California
$2.35M +$88.8K +300 +4%
BSPF
477
British Steel Pension Fund
United Kingdom
$2.32M -$545K -1,840 -20%
V
478
Veritable
Delaware
$2.31M -$845K -2,853 -28%
PVH
479
Psagot Value Holdings
Israel
$2.29M -$497K -1,677 -19%
DY
480
Dowling & Yahnke
California
$2.25M +$103K +347 +5%
EIP
481
Epoch Investment Partners
New York
$2.24M +$29.6K +100 +1%
PAG
482
Private Advisor Group
New Jersey
$2.23M +$405K +1,368 +25%
CS
483
Cannell & Spears
New York
$2.23M
MYAM
484
Meiji Yasuda Asset Management
Japan
$2.23M -$29.6K -100 -1%
Parallax Volatility Advisers
485
Parallax Volatility Advisers
California
$2.21M -$2.82M -9,532 -57%
AFG
486
American Financial Group
Ohio
$2.19M
DF
487
Donoghue Forlines
Massachusetts
$2.19M +$2.07M +6,984 New
Acadian Asset Management
488
Acadian Asset Management
Massachusetts
$2.19M -$1.46M -4,947 -41%
SLI
489
Sumitomo Life Insurance
Japan
$2.18M -$37.6K -127 -2%
CI
490
Conning Inc
Connecticut
$2.13M -$2.96K -10 -0.1%
OAM
491
Oxford Asset Management
United Kingdom
$2.12M -$2.27M -7,670 -53%
TSWM
492
Triangle Securities Wealth Management
North Carolina
$2.12M -$46.8K -158 -2%
FIM
493
Freedom Investment Management
Connecticut
$2.11M +$757K +2,556 +61%
OPPM
494
Opus Point Partners Management
New York
$2.09M +$269K +910 +16%
LIA
495
LS Investment Advisors
Michigan
$2.05M +$76.4K +258 +4%
MJRIC
496
Mogy Joel R Investment Counsel
California
$2.04M
VSI
497
Verde Servicos Internacionais
Brazil
$2.03M -$328K -1,109 -15%
TWA
498
TCI Wealth Advisors
Arizona
$2.02M -$888 -3 -0%
CCM
499
Cadence Capital Management
Massachusetts
$2.01M -$1.23M -4,141 -39%
OTPPB
500
Ontario Teachers' Pension Plan Board
Ontario, Canada
$2.01M -$960K -3,241 -34%

BIIB Hedge Fund Activity: Q3 2017 in Review

1,014 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Biogen (BIIB) for Q3 2017, worth a combined $59B — up 16% from $50.9B a quarter earlier.

Buyers outnumbered sellers: 99 funds opened new BIIB positions and 68 closed out — a net gain of 31 holders — while 380 added to existing stakes and 356 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $513M. The largest seller was BlackRock, cutting an estimated $344M.

  • 1,014 institutional investors held Biogen (BIIB) as of Q3 2017, up from 992 in Q2 2017.
  • Funds reported $59B of Biogen stock for Q3 2017, up 16% quarter-over-quarter.
  • 99 funds opened new Biogen positions in Q3 2017 and 68 closed out, a net change of +31 holders.
  • The largest Biogen buyer in Q3 2017 was T. Rowe Price Associates, an estimated $513M added.
  • The largest Biogen seller in Q3 2017 was BlackRock, an estimated $344M sold.

Based on aggregated 13F filings for Q3 2017.